JP2019501661A5 - - Google Patents

Info

Publication number

JP2019501661A5

JP2019501661A5 JP2018536892A JP2018536892A JP2019501661A5 JP 2019501661 A5 JP2019501661 A5 JP 2019501661A5 JP 2018536892 A JP2018536892 A JP 2018536892A JP 2018536892 A JP2018536892 A JP 2018536892A JP 2019501661 A5 JP2019501661 A5 JP 2019501661A5

Authority

JP

Japan

Prior art keywords

seq

immunotherapy

based composition

encoded

sequence

Prior art date

2017-01-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004027 cell Anatomy 0.000 claims description 58
• 206010028980 Neoplasm Diseases 0.000 claims description 27
• 239000013612 plasmid Substances 0.000 claims description 27
• 201000011510 cancer Diseases 0.000 claims description 25
• 108700011259 MicroRNAs Proteins 0.000 claims description 22
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 22
• 239000002679 microRNA Substances 0.000 claims description 22
• 239000004055 small Interfering RNA Substances 0.000 claims description 22
• 239000002245 particle Substances 0.000 claims description 21
• 102000004190 Enzymes Human genes 0.000 claims description 20
• 108090000790 Enzymes Proteins 0.000 claims description 20
• 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 claims description 20
• 108010026318 Geranyltranstransferase Proteins 0.000 claims description 20
• 239000013598 vector Substances 0.000 claims description 19
• 229940079593 drug Drugs 0.000 claims description 16
• 239000003814 drug Substances 0.000 claims description 16
• KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 claims description 15
• KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 claims description 15
• 230000037361 pathway Effects 0.000 claims description 15
• 239000013603 viral vector Substances 0.000 claims description 14
• 238000000034 method Methods 0.000 claims description 13
• 230000002401 inhibitory effect Effects 0.000 claims description 12
• 101710091045 Envelope protein Proteins 0.000 claims description 11
• 101710188315 Protein X Proteins 0.000 claims description 11
• 102100021696 Syncytin-1 Human genes 0.000 claims description 11
• 108700004026 gag Genes Proteins 0.000 claims description 8
• 108700004029 pol Genes Proteins 0.000 claims description 8
• 108700004030 rev Genes Proteins 0.000 claims description 8
• 230000003612 virological effect Effects 0.000 claims description 8
• 230000003213 activating effect Effects 0.000 claims description 7
• 210000004475 gamma-delta t lymphocyte Anatomy 0.000 claims description 7
• 238000004806 packaging method and process Methods 0.000 claims description 7
• 208000015181 infectious disease Diseases 0.000 claims description 5
• 101150098213 rev gene Proteins 0.000 claims description 4
• XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 claims description 4
• 229960004276 zoledronic acid Drugs 0.000 claims description 4
• 241000713666 Lentivirus Species 0.000 claims description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 3
• 238000009169 immunotherapy Methods 0.000 claims 53
• 239000000203 mixture Substances 0.000 claims 52
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 12
• 108090000623 proteins and genes Proteins 0.000 claims 9
• 102000004169 proteins and genes Human genes 0.000 claims 9
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 7
• 208000032839 leukemia Diseases 0.000 claims 5
• 201000009030 Carcinoma Diseases 0.000 claims 4
• 206010025323 Lymphomas Diseases 0.000 claims 4
• 206010027406 Mesothelioma Diseases 0.000 claims 4
• 206010035226 Plasma cell myeloma Diseases 0.000 claims 4
• 206010039491 Sarcoma Diseases 0.000 claims 4
• 201000000050 myeloid neoplasm Diseases 0.000 claims 4
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims 3
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 3
• 230000001225 therapeutic effect Effects 0.000 claims 3
• 102000003390 tumor necrosis factor Human genes 0.000 claims 2
• 230000002121 endocytic effect Effects 0.000 claims 1
• 230000001024 immunotherapeutic effect Effects 0.000 claims 1
• 238000001890 transfection Methods 0.000 claims 1
• 230000002068 genetic effect Effects 0.000 description 8
• 241000700605 Viruses Species 0.000 description 5
• 102000019034 Chemokines Human genes 0.000 description 4
• 108010012236 Chemokines Proteins 0.000 description 4
• 108091032955 Bacterial small RNA Proteins 0.000 description 3
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 102000001902 CC Chemokines Human genes 0.000 description 1
• 108010040471 CC Chemokines Proteins 0.000 description 1
• 108050006947 CXC Chemokine Proteins 0.000 description 1
• 102000019388 CXC chemokine Human genes 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102000000588 Interleukin-2 Human genes 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1